Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Electrical acupoint stimulation to prevent low blood pressure during TAVR anesthesia

Official title: The Influence of Electrical Acupoint Stimulation at Different Frequencies on Hemodynamics During Anesthesia Induction in Patients Undergoing TAVR Surgery

Run by Air Force Military Medical University, China · NCT07365345 · Data updated 2026-11-12

We test whether high- versus low-frequency electrical stimulation at three acupoints before anesthesia can reduce drops in blood pressure in people aged 60 and older having TAVR.

More Transcatheter Aortic Valve Replacement (TAVR) trials

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment150 (estimated)
SponsorAir Force Military Medical University, China
Academic / other
Locations1 site (Xi'an, Shannxi)
StatusRecruiting
StartedJanuary 30, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMarch 25, 2026
Trial IDNCT07365345 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged 60 or older who are scheduled for TAVR under general anesthesia with a BMI between 18 and 30 and without severe liver/kidney dysfunction, decompensated heart failure, active skin infection at stimulation sites, or implanted electrical devices.

Probably not a fit

Patients with hemodynamic instability, severe organ dysfunction, BMI outside 18–30, local skin damage or infection, or implanted electrophysiological devices are unlikely to benefit or will be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patients scheduled for TAVR under general anesthesia receive electrical stimulation at the acupoints Neiguan, Jianshi, and Baihui within 30 minutes before induction. Participants are assigned to receive either high-frequency or low-frequency stimulation and blood pressure changes during the anesthesia induction period are recorded. The primary comparison is the magnitude and incidence of hypotension and the need for vasoactive drugs during induction. Safety exclusions include implanted electrical devices, severe organ dysfunction, extreme BMI, active skin infection at stimulation sites, or preexisting hemodynamic instability.

Why it matters

Potential benefit: If successful, this approach could reduce anesthesia-induced drops in blood pressure during TAVR and lower the need for vasopressors, improving safety at induction.

How similar studies have gone: Prior small perioperative acupuncture studies have suggested acupoint stimulation can reduce anesthesia-related hypotension, but frequency-specific comparisons are limited and this protocol is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The age of the patients is 60 years or older;
* Patients who are scheduled to undergo TAVR surgery under general anesthesia;

Exclusion Criteria:

* Body mass index less than 18 kg/m2 or greater than 30 kg/m2;
* Hemodynamic instability (severe arrhythmia, decompensated heart failure);
* Hypotension after admission requiring intervention with vasoactive drugs;
* Severe liver or kidney dysfunction;
* Those who are contraindicated for electrical stimulation, including those with local skin damage, infection, or having implanted electrophysiological devices in the body.

Where it's running

  • Xijing Hospital, Fourth Military Medical University
    Xi'an, Shannxi, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • CHATEAU Registry: Real-world outcomes after TAVR

    This registry collects real-world data from adults who had TAVR between 2021 and 2025 to see how they do over time and how valve performance holds up.

    Recruiting Eunpyeong St. Mary's Hospital · Seoul · NCT07709858

  • Ciprofol and Fentanyl for LMA Insertion in Children: Finding the ED95 Dose

    This study tests the smallest effective single dose of ciprofol, given with fentanyl, to help placing a laryngeal mask airway in children aged 1–12 undergoing anesthesia.

    Recruiting Phase 4 Huazhong University of Science and Technology · Wuhan, Hubei · NCT07697404

  • CHORDS Cerebral Protection During TAVR

    This study tests whether using the CHORDS Cerebral Protection System during TAVR reduces brain embolic events compared to the Sentinel system in adults with severe aortic stenosis.

    Recruiting at 14 sites Resonova (Shanghai) Medtech Limited · Bengbu, Anhui and 14 other locations · NCT07648693

  • How the type of sedation affects recovery after TAVR

    This study will test whether three common sedation approaches (propofol, dexmedetomidine, or midazolam with fentanyl) change how people recover on the first day after transfemoral TAVR.

    Recruiting Phase 4 Endeavor Health · Glenview, Illinois · NCT07556523

  • Using 4D Flow MRI to characterize left ventricular failure

    This project will test whether automated 4D Flow MRI analysis can measure left ventricular dysfunction in adults with severe aortic stenosis who are scheduled for TAVR.

    Recruiting at 2 sites IRCCS Policlinico S. Donato · San Donato Milanese and 1 other locations · NCT07455292

  • Tracking progression and consequences of heart valve disease

    This project will follow adults with moderate or worse valve disease to see if clinical tests and imaging can predict when their condition will get worse.

    Recruiting at 15 sites Second Affiliated Hospital, Zhejiang University, School of Medicine · Fuzhou, Fujian and 14 other locations · NCT07267117

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.